Kestra Medical Technologies, Ltd. (KMTS) Misses Q2 EPS by 9c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq leads Wall Street lower on AI spending jitters; oil prices rebound
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Tweet
Share
E-mailGet Alerts KMTS Hot Sheet
Join SI Premium – FREE
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) reported Q2 EPS of ($0.67), $0.09 worse than the analyst estimate of ($0.58). Revenue for the quarter came in at $28.64 million, versus $26.5 million reported last year.
For earnings history and earnings-related data on Kestra Medical Technologies, Ltd. (KMTS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Scotiabank Names Top Utility Stocks Amid Data Center Growth
- Citi says housing sector contraction deepens as rates hit 7.5%
- Deepseek、Minimax Get License For Overseas Use - China Media
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
